11-644594-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_021008.4(DEAF1):c.1654G>A(p.Glu552Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000248 in 1,613,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_021008.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEAF1 | NM_021008.4 | c.1654G>A | p.Glu552Lys | missense_variant | Exon 12 of 12 | ENST00000382409.4 | NP_066288.2 | |
DEAF1 | NM_001293634.1 | c.1429G>A | p.Glu477Lys | missense_variant | Exon 11 of 11 | NP_001280563.1 | ||
DEAF1 | NM_001367390.1 | c.928G>A | p.Glu310Lys | missense_variant | Exon 12 of 12 | NP_001354319.1 | ||
DEAF1 | XM_047426251.1 | c.928G>A | p.Glu310Lys | missense_variant | Exon 12 of 12 | XP_047282207.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 249666Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135324
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1460894Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 726776
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74306
ClinVar
Submissions by phenotype
See cases Uncertain:1
ACMG categories: PM2,PP3 -
not provided Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 552 of the DEAF1 protein (p.Glu552Lys). This variant is present in population databases (rs765017164, gnomAD 0.007%). This missense change has been observed in individual(s) with clinical features of DEAF1-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 1375462). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DEAF1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Intellectual disability, autosomal dominant 24 Uncertain:1
This sequence variant is a single nucleotide substitution (G>A) at position 1654 of the coding sequence of the DEAF1 gene that results in a glutamic acid to lysine amino acid change at residue 552 of the DEAF1 transcription factor protein. This residue falls in the MYND zinc finger domain (UniProt). This is a previously reported variant (ClinVar 1375462) that has not been observed in individuals affected by a DEAF1-related disorder in the published literature, to our knowledge. This variant is present in 40 of 1613016 alleles (0.0025%) in the gnomAD population dataset. Bioinformatic tools are inconclusive if this amino acid change will be damaging or tolerated, and the Glu552 residue at this position is highly conserved across the vertebrate species examined. Studies examining the functional consequence of this variant have not been published, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this a variant of uncertain significance. ACMG Criteria: PM2 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at